SurgLine International, Inc.
SGLN · OTC
7/31/2012 | 7/31/2011 | 7/31/2010 | 7/31/2009 | |
|---|---|---|---|---|
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | – | – | -100% | – |
| Cost of Goods Sold | $0 | $0 | $0 | $0 |
| Gross Profit | $0 | $0 | -$0 | -$0 |
| % Margin | 34.4% | – | – | -770.5% |
| R&D Expenses | $0 | $0 | $0 | $0 |
| G&A Expenses | $2 | $0 | $0 | $0 |
| SG&A Expenses | $2 | $0 | $0 | $0 |
| Sales & Mktg Exp. | $0 | $0 | $0 | $0 |
| Other Operating Expenses | $0 | $0 | $0 | $0 |
| Operating Expenses | $2 | $0 | $0 | $0 |
| Operating Income | -$2 | -$0 | -$0 | -$1 |
| % Margin | -1,832.4% | – | – | -16,329.8% |
| Other Income/Exp. Net | -$1 | $0 | $0 | $1 |
| Pre-Tax Income | -$3 | $0 | $0 | $0 |
| Tax Expense | $0 | $0 | $0 | $0 |
| Net Income | -$3 | -$0 | -$1 | -$1 |
| % Margin | -2,408.9% | – | – | -24,857.9% |
| EPS | -0.001 | -0.01 | -0.01 | -0.01 |
| % Growth | 95% | 0% | 0% | – |
| EPS Diluted | -0.001 | -0.01 | -0.01 | -0.01 |
| Weighted Avg Shares Out | 5,347 | 483 | 326 | 215 |
| Weighted Avg Shares Out Dil | 5,347 | 483 | 326 | 215 |
| Supplemental Information | – | – | – | – |
| Interest Income | $0 | $0 | $0 | $0 |
| Interest Expense | $0 | $0 | $0 | $0 |
| Depreciation & Amortization | $0 | $0 | $0 | $0 |
| EBITDA | -$2 | -$0 | -$0 | -$0 |
| % Margin | -2,165.1% | – | – | -14,687.3% |